The evolution of drug-resistant malaria: the role of drug elimination half-life.

Por Hastings, Ian M, Watkins, William M, White, Nicholas J
Publicado em 2002

Temporal patterns of pyrimethamine resistance haplotypes in Kilifi, Kenya

Por Certain, Laura K., Briceño, Marnie, Kiara, Steven M., Nzila, Alexis M., Watkins, William M., Sibley, Carol Hopkins
Publicado em 2008

Hypoxia-Induced Expression of VEGF Splice Variants and Protein in Four Retinal Cell Types

Por Watkins, William M., McCollum, Gary W., Savage, Sara R., Capozzi, Megan E., Penn, John S., Morrison, David G.
Publicado no Exp Eye Res (2013)

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)

Por Lourens, Chris, Watkins, William M, Barnes, Karen I, Sibley, Carol H, Guerin, Philippe J, White, Nicholas J, Lindegardh, Niklas
Publicado em 2010

Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus

Por Ogutu, Bernhards R, Newton, Charles R J C, Muchohi, Simon N, Otieno, Godfrey O, Edwards, Geoffrey, Watkins, William M, Kokwaro, Gilbert O
Publicado em 2003

World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology

Por Barnes, Karen I, Lindegardh, Niklas, Ogundahunsi, Olumide, Olliaro, Piero, Plowe, Christopher V, Randrianarivelojosia, Milijaona, Gbotosho, Grace O, Watkins, William M, Sibley, Carol H, White, Nicholas J
Publicado em 2007